Session 39: Novel Approaches for Diagnostics and Treatment of Brain Tumors
Tracks
Hall 1
| Friday, October 2, 2026 |
| 8:00 AM - 9:30 AM |
Details
Kostas Fountas, Vincent Lubrano
Speakers & Chairs
Kostas Fountas
Chair
Dr. Oliver Bozinov
Chairman
Hoch Health Ostschweiz
LITT for brain tumors - where do we stand?
8:00 AM - 8:10 AM
Alexandre Carpentier
FUS (Focused Ultrasound) for brain tumors
8:10 AM - 8:20 AM
Dr. Michael Müther
Consultant
University Hospital Münster
Oncological Neurosurgery Beyond Resection: Emerging Local Therapies for Glioma
8:20 AM - 8:30 AM
Prof Franz Ricklefs
Full Professor, Attending
University Medical Center Hamburg-Eppendorf
Epigenetic Neural Score Predicts Survival Benefit from Immune Checkpoint Inhibition in IDH-Wildtype Glioblastoma: Multicenter Discovery, Prospective Validation, and Clinical Utility Analysis
Ms Maria Charlotte Brielmaier
Resident Doctor
Charité - Universitätsmedizin Berlin
Establishment of Intraoperative Nanopore-Sequencing for Brain Tumors
Mrs. Hermine QUARDON
Phd
Creatis Laboratory
Intraoperative Optical Identification of Glioma Infiltration at Tumor Margins Using Dual-Excitation 5-ALA Fluorescence Spectroscopy
Dr Patrick Kuppler
MD
University Medical Center Schleswig-Holstein, Campus Lübeck
Rapid Tissue Differentiation in OCT-Guided Brain Tumor Resection
Dr. Massimiliano Del Bene
Dr
Fondazione IRCCS Istituto Neurologico "Carlo Besta"
Blood–Brain Barrier Opening Does Not Increase Plasma EV Concentration in Glioblastoma Patients
Dr Melika Akhbari
Junior Research Fellow
University Of Oxford
Development of an intra-operative mass-spectrometry tissue classifier for real-time tissue analysis during glioma surgery
Dr charles-henry Mallereau
MD
Strasbourg University Hospital
Prolonged Opening of the Blood–Brain Barrier Following Cerebral Cryoablation: A Study in Non–Tumor–Bearing Pigs
Discussion
Discussion
9:25 AM - 9:30 AM
Vincent Lubrano
Chair
